WHO expects hydroxychloroquine safety findings by mid-June
The World Health Organization (WHO) on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug's use in a large trial on COVID-19 patients.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: COVID-19 | Health | Hydroxychloroquine | International Medicine & Public Health | Malaria | WHO